SHALBY LIMITED
SHALBY · Defence · NSE
₹159
Current Market Price
Under Review— We don’t have enough data to publish a fair value estimate for SHALBY yet. Reason: Data Limited.
Updated just now
YieldIQ Score
—
Piotroski F-Score
3/9
Economic Moat
None
Confidence
12%
ROE
0.6%
Debt/Equity
0.48
WACC
11.1%
Market Cap
₹1,709 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
10.7%
Return on capital employed
EV / EBITDA
17.1×
Enterprise multiple
Debt / EBITDA
4.3×
Leverage vs earnings
Interest Coverage
2.6×
EBIT covers interest
Current Ratio
1.45×
Short-term liquidity
Asset Turnover
—
Revenue per ₹ of assets
Revenue CAGR (3Y)
12.6%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
Ratio Trends
SHALBY · last 8 annual periods
ROE
0.6%
ROCE
10.7%
Operating Margin
—
Debt / Equity
0.48×
PE
103.6×
EV / EBITDA
9.5×
Historical Financials
SHALBY · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 NSE_XBRL | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹419 Cr | ₹699 Cr | ₹800 Cr | ₹928 Cr | ₹1081 Cr | +26.8% |
| EBITDA | — | ₹128 Cr | ₹158 Cr | ₹195 Cr | ₹157 Cr | +5.2% |
| EBIT | ₹59.1 Cr | ₹85.0 Cr | ₹111 Cr | ₹144 Cr | — | +25.0% |
| PAT | ₹42.9 Cr | ₹54.1 Cr | ₹67.7 Cr | ₹84.1 Cr | ₹6.2 Cr | -38.3% |
| EPS (diluted) | ₹3.97 | ₹5.00 | ₹6.27 | ₹7.77 | — | +18.3% |
| CFO | ₹82.4 Cr | ₹18.9 Cr | ₹67.8 Cr | ₹19.6 Cr | ₹-4.3 Cr | — |
| CapEx | — | ₹-75.4 Cr | ₹-18.5 Cr | ₹-47.1 Cr | ₹-71.4 Cr | — |
| FCF | — | ₹-56.5 Cr | ₹49.3 Cr | ₹-27.5 Cr | ₹-75.8 Cr | — |
| Total Assets | — | ₹1194 Cr | ₹1281 Cr | ₹1608 Cr | ₹1704 Cr | +9.3% |
| Total Debt | — | ₹174 Cr | ₹181 Cr | ₹378 Cr | ₹476 Cr | +28.6% |
| Shareholders' Equity | — | ₹876 Cr | ₹928 Cr | ₹1000 Cr | ₹992 Cr | +3.2% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
SHALBY vs 2 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
GPTHEALTH GPTHEALTH | — | — | Pending | 15.7% | — |
INDRAMEDCO INDRAMEDCO | — | — | Pending | 24.8% | 18.6× |
Click a ticker to view its fair-value analysis.
Dividend History
6 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹4.40/sh
Last payout
2024-09-19
₹1.20
Peak payout
₹1.20
Trailing yield
—
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
Risk Analysis
Volatility & drawdown
Risk profile of SHALBY →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for SHALBY →
Compare
Head-to-head with peers
Compare SHALBY side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse SHALBYNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.